Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about p16^INK4a: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| senescence | biomarker_for | phenotype | 0.70 |
| CCF formation | activates | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| p16^INK4a-CCF Axis as Senolytic Timing Biomarker | 0.805 | molecular-biology | What is the optimal therapeutic window t |
| Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senesc | 0.564 | neuroinflammation | What molecular mechanisms drive the tran |
Scientific analyses that reference this entity
molecular biology | 2026-04-07 | 8 hypotheses Top: 0.805
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413] | Yang H, Li Y, Su J, Zhang H, Zhu W et al | Front Immunol | 2026 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning p16^INK4a in their description or question text
No additional research found